Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997018799) USE OF A TNF ALPHA ANTAGONIST FOR TREATING NEUROGENIC SKIN REDNESS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/018799 International Application No.: PCT/FR1996/001688
Publication Date: 29.05.1997 International Filing Date: 28.10.1996
Chapter 2 Demand Filed: 28.05.1997
IPC:
A61K 31/4402 (2006.01) ,A61K 31/52 (2006.01) ,A61K 31/522 (2006.01) ,A61K 38/00 (2006.01) ,C07K 16/24 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4402
only substituted in position 2, e.g. pheniramine, bisacodyl
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
52
Purines, e.g. adenine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519
ortho- or peri-condensed with heterocyclic rings
52
Purines, e.g. adenine
522
having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
24
against cytokines, lymphokines or interferons
Applicants:
L'OREAL [FR/FR]; 14, rue Royale F-75008 Paris, FR
Inventors:
DE LACHARRIERE, Olivier; FR
BRETON, Lionel; FR
Agent:
LHOSTE, Catherine; L'Oréal - D.P.I. 90, rue du Général-Roguet F-92583 Clichy Cédex, FR
Priority Data:
95/1372920.11.1995FR
Title (EN) USE OF A TNF ALPHA ANTAGONIST FOR TREATING NEUROGENIC SKIN REDNESS
(FR) UTILISATION D'UN ANTAGONISTE DE TNF-ALPHA POUR LE TRAITEMENT DES ROUGEURS CUTANEES D'ORIGINE NEUROGENE
Abstract:
(EN) The use of a TNF alpha antagonist in or for preparing a topical cosmetic, pharmaceutical or dermatological composition for treating neurogenic skin redness and particularly rosacea, is disclosed.
(FR) L'invention se rapporte à l'utilisation d'un antagoniste de TNF-alpha dans ou pour la préparation d'une composition cosmétique, pharmaceutique ou dermatologique à application topique, pour traiter les rougeurs cutanées d'origine neurogène, et notamment la rosacée.
Designated States: BR, CA, CN, HU, JP, KR, MX, PL, RU
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
ES2127613EP0774250JPH11501665CN1202822CA2235038DE000069601026
KR1019990067052FR2741262